Halozyme Therapeutics, Inc.

BI Asset Management Fondsmaeglerselskab A/S HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

246,143

Value ($000)

16,565

Weight

0.1%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	16,565	0.1%	246,143	12/31/2025
2025 Q3	11/5/2025	21,192	0.2%	288,952	9/30/2025
2025 Q2	8/14/2025	23,146	0.2%	444,947	6/30/2025